Floatz logo

Panobinostat

Medulloblastoma

Washington University School of MedicineSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

22 Active assets in the Medulloblastoma cohort.

Asset / SponsorPhaseRating
Irinotecan
Pfizer
Phase 2BB
Nivolumab
Bristol-Myers Squibb
Phase 2B
Cyclophosphamide
Theodore S. Johnson
Phase 2B
Indoximod
Theodore S. Johnson
Phase 2B
ETOPOSIDE
Theodore S. Johnson
Phase 2B

View all 50 →

Same molecule, other indications

Panobinostat is also rated in:

Hodgkins lymphomaDormant
BB
Indicative ·
68 / 100
View asset →
Non-Small Cell Lung CancerDormant
BB
Indicative ·
66 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →